M&A Deal Summary |
|
---|---|
Date | 2016-04-28 |
Target | St. Jude Medical |
Sector | Medical Products |
Buyer(s) | Abbott Laboratories |
Deal Type | Add-on Acquisition |
Deal Value | 25.0B USD |
Advisor(s) | Guggenheim Securities (Financial) Gibson, Dunn & Crutcher (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1888 |
Sector | Medical Products |
Employees | 114,000 |
Revenue | 40.1B USD (2023) |
Abbott Laboratories is a diversified, global provider of diagnostics, medical devices, nutrition and pharmaceuticals. Abbott Laboratories was incorporated in 1888 and is headquartered in North Chicago, Illinois.
DEAL STATS | # |
---|---|
Overall | 31 of 35 |
Sector (Medical Products) | 16 of 20 |
Type (Add-on Acquisition) | 31 of 35 |
State (Minnesota) | 2 of 3 |
Country (United States) | 24 of 28 |
Year (2016) | 3 of 3 |
Size (of disclosed) | 1 of 28 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-02-05 |
Kalila Medical
Campbell, California, United States Kalila Medical, Inc. is a medical device company developing next-generation access technologies used in cardiac electrophysiology procedures for the treatment of heart rhythm disorders, including atrial fibrillation. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-09-16 |
Abbott Medical Optics
Santa Ana, California, United States Abbott Medical Optics, Inc. is a manufacturer of ophthalmic surgery products and is known for world-class intraocular lenses used in cataract surgery. The World Health Organization estimates that approximately 20 million people are blind from age-related cataracts and that there are at least 100 million eyes with compromised visual acuity caused by cataracts. These numbers are steadily rising due to population growth and increasing life expectancy. |
Sell | $4.3B |